Ultra-LEAFTM Purified anti-human HLA-A,B,C [W6/32]

The University of Virginia awarded contract A207_PO-0445213 to BioLegend Inc. on June 4, 2026, for the procurement of laboratory reagents and research materials. The prime contractor is delivering one unit of Ultra-LEAF™ Purified anti-human HLA-A,B,C [W6/32], a monoclonal antibody product used in immunological research and flow cytometry applications. The deliverable is consigned to Amy D Adams at the contracting organization. The contract is executed in Virginia and represents a transaction valued at $104.30.

The contract represents a straightforward purchase order for specialized scientific materials required by the University of Virginia's research operations. No annual value, extended contract amount, or performance period beyond the award date of June 4, 2026, is specified in the available documentation, indicating this is a discrete purchase order transaction rather than an ongoing service contract. BioLegend Inc., the awarded prime contractor, is responsible for fulfilling the single line item delivery of the specified immunological reagent to the designated recipient.